Skip to main content
. 2018 Feb 2;5(4):e005141. doi: 10.1099/jmmcr.0.005141

Table 1. Serology profiles of the 13 individuals who seroconverted.

Positive serology results are shown in bold.

1st serology test 2nd serology test 3rd serology test 4th serology test
Gender Study no. No. of days since exposure MBA GAA No. of days since exposure MBA GAA No. of days since exposure MBA GAA No. of days since exposure MBA GAA
F 4 70 0 0 124 16 0 452 32 16
F 8 74 16 64 134 0 256 333 0 128
F 9 69 0 0 131 0 256 413 0 32
F 10 45 0 128 114 0 512
F 11 63 0 0 161 0 256
F 15 53 0 256 61 0 2048 268 0 256
M 21 61 0 0 83 64 512 102 32 128 322 0 64
M 25 50 0 128 73 0 256 267 0 512
M 28 62 256 0 413 64 0
M 30 71 0 256 106 0 512
M 31 61 0 512 81 0 1024 426 0 256
M 32 61 0 512 124 0 512 183 0 256 269 0 128
M 36 74 256 1024 104 64 1024 284 128 128

F, Female; M, male.